European Forum for Qualified Person for Pharmacovigilance (QPPV)
|
|
- Brooke Greer
- 5 years ago
- Views:
Transcription
1 European Forum for Qualified Person for Pharmacovigilance (QPPV) October 2018 (Pre-conference Workshops on 9 October) Renaissance London Heathrow Hotel, Heathrow, London, UK PROGRAMME CO-CHAIRS Elspeth McIntosh Director, Castle Pharmacovigilance Limited Margaret Walters Deputy EU QPPV, Merck Sharp & Dohme Ltd. PROGRAMME COMMITTEE Vicki Edwards Vice President, Pharmacovigilance Excellence and QPPV, AbbVie Doris Stenver Chief Medical Officer, Danish Medicines Agency Michael Richardson International Head of GPV&E and EU QPPV, Bristol-Myers Squibb Pharmaceuticals Ltd. Brian Edwards Principal Consultant, Pharmacovigilance and Drug Safety, NDA Regulatory Science Ltd. Winrich Rauschning QPPV, BioLitec Pharma Barbara De Bernardi EU QPPV Deputy, and Head of EU Safety Office, Pfizer Italia S.r.l. Peter De Veene QPPV, Alexion Pharmaceuticals Overview This is still the only forum designed for QPPVs by QPPVs, now in its 12th year and still going strong. This Forum continues to identify key trends requiring QPPV awareness, input and oversight. This year s objectives, as shown below, build on past successes and have been shaped by valuable feedback provided by participants of the past eleven meetings, plus many years of QPPV and Regulator interaction at this Forum. Over time, one of the key successes of the Forum has been the ability to secure continuing support and involvement of key regulators. Sessions have been open and interactive with attendees appreciating opportunities to raise challenging issues in an informal environment. This 12th QPPV Forum continues this successful approach. Objectives Hear the latest updates and hot topics relating to the role of the QPPV Explore long term PV visions, future directions of the PV world, and potential impact on the role of QPPV Network with colleagues and meet regulators Learn from and share experience and ideas with like-minded QPPVs in a neutral environment Take away practical hints and tips Better understand regulatory and inspectorate expectations of the QPPV Identify the expanded expectations of the role in the context of the continually evolving regulatory framework Examine current areas of real challenge Magnus Ysander EU QPPV and Head Risk Management & Pharmacovigilance Excellence, AstraZeneca R&D Angela van der Salm Director Pharmacovigilance, Managing Partner, DADA Consultancy B.V. Find out more at DIAglobal.org/QPPV
2 PRE-CONFERENCE WORKSHOPS TUESDAY, 9 OCTOBER HALF-DAY WORKSHOPS, 12:00-17:30 Limited Places Available WORKSHOP 1: INTRODUCTION TO THE ROLE OF QPPVS Meeting Room: Blackfriars As a result of feedback from previous years we are repeating this workshop aimed at those EU QPPVs who are new to the role, need to refresh on the role, those who support the QPPV and those who are thinking of taking on a QPPV role. It may also be of interest to any QPPV who wish to refresh their knowledge. The session will focus on providing an understanding of, and update on, the QPPV role, legal considerations for QPPVs and the practical issues facing QPPVs in a range of company sizes and types. Workshop Chairs: Elspeth McIntosh, Director, Castle Pharmacovigilance Limited Magnus Ysander, EU QPPV and Head Risk Management & Pharmacovigilance Excellence, AstraZeneca WORKSHOP AGENDA 12:00 Registration (Arora Lobby) and Lunch (Market Garden Restaurant) 13:00 What does it mean to be a QPPV? Elspeth McIntosh, Director, Castle Pharmacovigilance Ltd. 13:45 QPPV Legal Issues Chris Foreman, Director, Legal Affairs, Mid-Europe II Region, Merck Sharp & Dohme (Europe) Inc., Nordic Region 14:15 The Small Pharma QPPV Elspeth McIntosh, Director, Castle Pharmacovigilance Ltd. 14:45 COFFEE BREAK (ARORA LOBBY) 15:15 QPPV oversight and the view from Big Pharma Magnus Ysander, EU QPPV and Head Risk Management & Pharmacovigilance Excellence, AstraZeneca 15:45 Practical Issue for QPPVs: Presentations to highlight the QPPV role in Business partner management and Outsourcing Quality oversight and processes and Inspection Pharmacovigilance System Master File (PSMF) Elspeth McIntosh, Director, Castle Pharmacovigilance Limited Magnus Ysander, EU QPPV and Head Risk Management & Pharmacovigilance Excellence, AstraZeneca 16:45 Panel Discussion 17:30 Close out Seperate Registration Required WORKSHOP 2: THE PSMF: WHERE ARE WE TODAY AND WHERE DO WE WANT TO GO? Meeting Room: Tower The purpose of this tutorial is to share knowledge and come up with some best practices between participants so that delegates leave the session better equipped and with an informal network of colleagues to tap into for working on the PSMF outside the EU. Workshop Chairs: Dionne Usher, Senior Specialist, EU QPPV Office, MSD Maria Wishart, Deputy EU Qualified Person for Pharmacovigilance, AstraZeneca Willemijn Van Der Spuij, Director International Operations & PV Excellence, Bristol-Myers Squibb Learning Objectives: Exploring the current PSMF requirements and challenges across the world and discuss practical solutions to simplify work. Discuss and understand feedback received on existing PSMFs, sharing of strategies and processes. Encourage participants to work towards an approach that ensures compliance, good quality, simplification to deliver what is needed whilst eliminating duplication wherever possible Audience: PV/Industry experts involved in PSMF coordination and/ or maintenance. Level: PV audience; beginners and advanced, trying to better understand the PSMF landscape and requirements around the globe WORKSHOP AGENDA 12:00 Registration (Arora Lobby) and Lunch (Market Garden Restaurant) 13:00 Introduction and Welcome 13:00 PSMF: Where we are Today: Legislative Update - sharing of information from Industry Group and DIA meeting 14:00 Audit and Inspections. Feedback on PSMFs EU/ex EU Dionne Usher, Senior Specialist, EU QPPV Office, MSD 14:45 COFFEE BREAK (ARORA LOBBY) 15:00 Building your PSMF (EU vs ex-eu) Maria Wishart, Deputy EU Qualified Person for Pharmacovigilance, AstraZeneca 15:45 The Ideal Global PSMF; the Future Willemijn Van Der Spuij, Director International Operations & PV Excellence, Bristol-Myers Squibb 16:30 Workshop feedback and Q&A 17:00 Close out Seperate Registration Required
3 CONFERENCE DAY ONE WEDNESDAY, 10 OCTOBER Meeting Room: Westminster 08:00 REGISTRATION AND WELCOME COFFEE 09:00 SESSION 1 KEY NOTES: CHANGE IS IN THE AIR Margaret Walters, Deputy EU QPPV, Merck Sharp & Dohme Ltd. The oversight of how drugs benefit and expose patients to risk is changing dramatically, driven by legislation, new therapies, unprecedented access to information and new unexpected challenges. A QPPV has to understand these forces, think creatively and be adaptable, to ensure industry manages their medicines and protects patients whilst ensuring optimal access and benefit to treatment. Approaching Change as an Opportunity Heather Bewers, Director, Change is an Opportunity Limited Pharmacovigilance in the next 5 years, The Industry Vision Vicki Edwards, Vice President, Pharmacovigilance Excellence and QPPV, AbbVie Managing Sudden Change - Experience with a Cyber Attack Janet Hormbrey, Head Global Pharmacovigilance, Merck & Co, Inc. 10:40 COFFEE BREAK (WESTMINSTER LOBBY) 11:10 SESSION 2 HOT TOPICS INDUSTRY PERSPECTIVES, WHAT DO I NEED TO KNOW? Vicki Edwards, Vice President, Pharmacovigilance Excellence and QPPV, AbbVie This will be year four for this very popular session. Typically the session invites speakers who are leading discussions between industry trade associations and Regulatory Authorities on the key issues of the moment. The session provides insight into what are the hot topics under discussion, what progress has been made and what are the next steps. The session is of value to participants from both large and small companies alike as there is limited attendance possible at the public meetings with EMA so this is a fantastic opportunity to hear about these topics from individuals who are directly involved. The session consists of a series of short, concise presentations that cover the key messages. This session is always a crowd pleaser! Update on collection of safety data from PSPs Sue Rees, EU QPPV, Executive Director, Global Patient Safety, Amgen Ltd. Update on EV new functionalities Margaret Walters, Deputy EU QPPV, Merck Sharp & Dohme Ltd. Update on RSI Willemijn Van Der Spuij, Director International Operations & PV Excellence, Bristol-Myers Squibb Country level signal notification requirements Willemijn Van Der Spuij, Director International Operations & PV Excellence, Bristol-Myers Squibb EV Signalling Metrics Valerie E. Simmons, EU QPPV, Global Patient Safety, Eli Lilly and Company Ltd. 12:40 LUNCH (MARKET GARDEN RESTAURANT) 14:00 SESSION 3 HOT TOPICS A REGULATOR S PERSPECTIVE? DO YOU KNOW WHAT WE ARE DOING? Maarten Lagendijk, Pharmacovigilance Coordinator, Medicines Evaluation Board (MEB) Menno Van Der Elst, PRAC member, Medicines Evaluation Board (MEB) The activities in the Pharmacovigilance Risk Assessment Committee (PRAC) covers a wide range of procedures, and the level of experience has reached a high level of matureness more than 5 years after the 2012 EU pharmacovigilance legislation came into force. For the QPPV it is important to keep abreast with the PRAC activities, and the current session will provide valuable insight into the functioning of the PRAC. Which are the current hot topics the committee is dealing with? Who are the most important stakeholders and how does the PRAC cooperate with them? Answers to these and many more questions will be provided in this session. Disclosure Policy Unless otherwise disclosed, DIA acknowledges that the statements made by speakers are their own opinion and not necessarily that of the organisation they represent, or that of the DIA. Speakers and agenda are subject to change without notice. Recording during DIA sessions is strictly prohibited without prior written consent from DIA.
4 An update from the Pharmacovigilance Risk Assessment Committee (PRAC) Doris Stenver, Chief Medical Officer, PRAC member, Danish Medicines Agency Menno Van Der Elst, Alternate PRAC member, Medicines Evaluation Board (MEB) Anja van Haren, EudraVigilance Coordinator, Pharmacovigilance, Medicines Evaluation Board (MEB) 15:30 COFFEE BREAK (WESTMINSTER LOBBY) 16:00 SESSION 4 ARE WE MANAGING THE RIGHT RISK IN THE RIGHT WAY? Magnus Ysander, EU QPPV and Head Risk Management & Pharmacovigilance Excellence, AstraZeneca One and a half year since the significant GVP V revision, experiences from both regulators and industry are shared and reflected on. Has the new wave of RMPs worked as expected? What are the remaining challenges and how can they be approached? What is the next evolution in risk management? Jane Feron, Pharmacovigilance and Regulatory Compliance, GRAPSQA, AstraZeneca Randip Kahlon, Implementation Lead - Global Safety Risk Management, BMS 17:30 END OF THE DAY 18:30 DINNER (WATERLOO SUITE) Access Presentations As a benefit of your registration, presentations are made available on the DIA website. To access presentations, go to and click on Sign in at the very top. Once you have successfully logged in, click on Welcome on the top, then My Account and on the left, go to My Presentations No paper copies of the presentations will be provided. NOTE: If a presentation is not available, the speaker either did not agree to publish it or did not provide us with the presentation. Updated versions of the slides will be made available shortly after the conference. Certificate of Attendance A Certificate of Attendance will be sent electronically fter the conference. Please note certification requires full attendance. For more information please liaise with our DIA Contact Centre on Basel@DIAglobal.org or call Evaluation We value your feedback on the content and organisation of this conference. The electronic survey will be sent to you after the conference and can also be accessed through the following link: Conference Venue Renaissance London Heathrow Hotel Bath Road Hounslow, TW6 2AQ +44 (0) Continuing Education DIA meetings and training courses are generally approved by the Commission for Professional Development (CPD) of the Swiss Association of Pharmaceutical Professionals (SwAPP) and the Swiss Society of Pharmaceutical Medicine (SGPM) and will be honoured with credits for pharmaceutical medicine. All participants are eligible for credits. About DIA DIA is the global connector in the life sciences product development process. Our association of thousands of members builds productive relationships by bringing together regulators, innovators, and influencers to exchange knowledge and collaborate in an impartial setting. DIA s network creates unparalleled opportunities for exchange of knowledge and has the inter-disciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, non-profit organisation has its Global Center in Washington, DC, USA with the European office in Basel, Switzerland, and additional regional offices in Horsham, Pennsylvania, USA; Tokyo, Japan; Mumbai, India; and Beijing, China. For more information, visit or call DIA:
5 DAY TWO THURSDAY, 11 OCTOBER 2018 Meeting Room: Westminster 08:00 WELCOME COFFEE (WESTMINSTER LOBBY) 08:30 SESSION 5 ARE WE LOOKING AT THE RIGHT THING IN THE RIGHT PLACE? - EUDRAVIGILANCE SIGNALING EXPERIENCE Peter De Veene, QPPV, Alexion Pharmaceuticals Winrich Rauschning, QPPV, BioLitec Pharma In October 2018 signaling in EV will have been mandatory for about 7 months. Experts from EMA, large and small pharma will review their experience and discuss points like: Are we looking at the right thing? Are we identifying signals in a timely manner? How complementary is this approach to established sources and methods? Speakers: Alternative Data sources for Signal Detection Phil Tregunno, Interim Group Manager, Vigilance, Intelligence and Research Group, Medicines and Healthcare products Regulatory Agency (MHRA) Feedback to Signaling in Eudravigilance Big Pharma Perspective Yusuf Tanrikulu, Deputy EU QPPV, F-Hoffmann-La Roche AG Eudravigilance Signal Experience Small Pharma Perspective Christina Alma Strom Moller, Head DSP and EU-QPPV, Swedish Orphan Biovitrum AB 10:00 COFFEE BREAK (WESTMINSTER LOBBY) 10:30 SESSION 6 AM I COMPLIANT ENOUGH? Angela van der Salm, Director Pharmacovigilance, DADA Consultancy B.V. Elspeth McIntosh, Director, Castle Pharmacovigilance Limited The actions required to demonstrate compliance may vary depending on company size, products and complexity of processes. This session will look at challenges and potential solutions for small/medium sized companies across a range of activities which affect QPPV oversight. International Infrastructure Challenges (Small vs Large Company) Peter De Veene, QPPV, Alexion Pharmaceuticals Small Pharma Challenges and Outsourcing Angela van der Salm, Director Pharmacovigilance, DADA Consultancy B.V. Challenges in Compliance and Audits Martijn van de Leur, Deputy QPPV, Vifor Pharma Challenges in Computer System Validation David Stokes, Director and Principal Consultant, Convalido Panel Discussion with Q&A 12:00 LUNCH (MARKET GARDEN RESTAURANT) 13:00 SESSION 7 ARE YOU COMPLIANT ENOUGH? - AUDITS, INSPECTIONS AND QMS Session Chairs: Barbara De Bernardi, EU QPPV Deputy, and Head of EU Safety Office, Pfizer Italia S.r.l. Helen Powell, Principal Consultant, NDA Regulatory Science Ltd. The QPPV role includes oversight over the functioning of the PV system in all relevant aspects to ensure effective compliance with applicable EU legislation is maintained. However, distilling out what is truly required out from the nice to have or from subjective interpretations is key to avoid allocation of valuable resources without real gain. This session will focus on current challenges with compliance interpretation and implementation from the perspectives of inspectors, companies and auditors Joanna Harper, Expert Inspector, GPvP, Medicines and Healthcare products Regulatory Agency (MHRA) Helen Powell, Principal Consultant, NDA Regulatory Science Ltd. Panel Discussion with Q&A Margaret Walters, Deputy EU QPPV, Merck Sharp & Dohme Ltd.
6 14:30 COFFEE BREAK (WESTMINSTER LOBBY) 15:00 SESSION 8 AM I IMPACTED BY BREXIT? Vicki Edwards, Vice President, Pharmacovigilance Excellence and QPPV, AbbVie Brian Edwards, Principal Consultant, Pharmacovigilance and Drug Safety, NDA Regulatory Science Ltd. This session will address some of the uncertainty surrounding the QPPV role and Brexit. What are practical implications of Brexit for UK based QPPVs? What is the impact for MAHs if QPPV moves and the team remains UK based? What is the legal situation concerning the definition reside and operate in the EU? Does this mean meeting rules for residency rather than just work out of? Will there be an impact on the deputy QPPV (or back-up )? These questions and more we ll try and answer in what promises to be a lively discussion. Speakers: Mick Foy, Head of Pharmacovigilance Strategy, Vigilance Intelligence and Research Group, Medicines and Healthcare products Regulatory Agency (MHRA) Turning Confusing Political Scenarios into Workable Plans Tim Sarson, Partner, Life Sciences Lead for Brexit, KPMG Vicki Edwards, Vice President, Pharmacovigilance Excellence and QPPV, AbbVie Elspeth McIntosh, Director, Castle Pharmacovigilance Limited 16:30 END OF CONFERENCE
7 NOTES
8 Stay Connected Navigate DIA Meetings from Your Smart Device with DIA s App The DIA Global App is designed to enhance your meeting experience and provide valuable information in one place. With the mobile app you have the conference at your fingertips: Create and manage your agenda Search for speakers and attendees to connect and network Get the app: Download & Install: type DIA GLOBAL in the App store or in Google Play Sign in with the address you used to register for the event If needed, use the reset password link to set your password Need assistance? Please feel free to ask one of our staff.
The Evolution of Policy 0070: EMA Clinical Data Publication
The Evolution of Policy 0070: EMA Clinical Data Publication 6-7 December 2017 Millennium Hotel London Mayfair, London, UK OVERVIEW PROGRAMME COMMITTEE Robert Paarlberg Principal, Paarlberg & Associates,
More informationAnnual Benefit-Risk Workshop
Annual Benefit-Risk Workshop Implementing an Internationally Acceptable Framework for the Benefit- Risk Assessment of Medicines: How close are we to this objective? 20-21 June 2013 PROGRAMME Venue: The
More informationDammika Peiris, Senior Pharmacovigilance Manager and Head of Chugai Pharma Europe
Key Speakers: Paul Dolin, Head of Pharmacoepidemiology, Takeda Pharmaceuticals Dr. Katrin Freund, Project Excellence Manager (Social Media) Drug Safety & Epidemiology, Novartis Pharma GmbH Dr. Heike Schoepper,
More informationPharmacovigilance Inspection Metrics Report
April 2013 - March 2014 Pharmacovigilance Inspection Metrics Report Introduction During the period 01 April 2013 to 31 March 2014, the Pharmacovigilance inspectorate conducted 56 inspections of Marketing
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More informationMay 13, 2015 London Life Sciences College Cristina Menendez Ruiz
May 13, 2015 London Life Sciences College is open to in-house counsel, regulatory personnel at pharmaceutical companies and regulators. There is no registration fee to attend this exclusive event. For
More informationCurrent Status and Challenges of Bilateral/Multilateral Meetings
Current Status and Challenges of Bilateral/Multilateral Meetings Junko Sato, PhD International Liaison Officer PMDA 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views and
More informationOracle Suite Update Update of the Argus Suite Release Roadmap Speaker: Industry, Oracle
Wednesday October 18 6:00 9:00pm Cocktail Reception Kick off AUG Boston by mingling with your peers while enjoying cocktails and an array of appetizers. Apropos Restaurant, lobby level, Boston Sheraton
More informationInter-Association Task Force
Inter-Association Task Force Presentation to EMA Workshop Prevention of Drug Shortages Based on Quality and Manufacturing Issues 9 th October 2015 1 Topics for Today Background and history of task force
More informationWorking together to achieve shared goals in product packaging and labelling
Working together to achieve shared goals in product packaging and labelling New for 2018 In follow up to the 10 year anniversary of the flagship Pharma Packaging and Labelling East Coast event in February
More informationMedical Education Activities
Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time
More informationMastering Environmental Monitoring
pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org
More informationCorporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
More informationPROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
More informationWorkshop on. Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review?
Workshop on Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review? 6 7 December 2011 PROGRAMME Intercontinental Hotel, Kuala
More informationBuilding quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA?
Workshop on Building quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA? 2 nd & 3 rd December 2013 Sheraton Heathrow Airport Hotel, UK PROGRAMME Organisers:
More informationPre- and post-authorisation regulatory support for SMEs
25 March 2013 EMA/214813/2013 Human Medicines Development and Evaluation Pre- and post-authorisation regulatory support for SMEs 26 April 2013 European Medicines Agency, London, United Kingdom 7 Westferry
More informationMastering Environmental Monitoring
pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org
More information6 & 7 December. current concepts for. Smart health in orthopaedics. congress.
9th edition 6 & 7 December 2018 congress Trans-atlantic current concepts for Smart health in orthopaedics Congress Guide 2018 It is our pleasure to announce the 9 th IMUKA Congress The European Current
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More informationEnpr EMA. Enpr-EMA. European Network of Paediatric Research at the European Medicines Agency
Enpr EMA European Network of Paediatric Research at the European Medicines Agency Enpr-EMA European Network of Paediatric Research at the European Medicines Agency An agency of the European Union Enpr
More informationGMPs FOR CURRENT TIMES
A MUST ATTEND GMP event for all pharmaceutical companies! GMPs FOR CURRENT TIMES APRIL 9-10, 2019 ORLANDO, FLORIDA Program produced by REGISTER EARLY! The top producer of premier pharmaceutical conferences
More informationThe Association s high-level visit to Hong Kong in April 2018
The Association s high-level visit to Hong Kong in April 2018 In April 2018, Kimberly N Ellison-Taylor, Chairman, Association of International Certified Professional Accountants & Immediate Past Chairman,
More informationMastering Environmental Monitoring
PDA Europe Training Course The Parenteral Drug Association presents: Mastering Environmental Monitoring 4-5 September 2018 Wattwil Switzerland Training & Education Program europe.pda.org PDA Education
More informationMidwest Financial Reporting Symposium
EARLY BIRD DISCOUNT Register by August 30, 2016 2016 Illinois CPA Society Tuesday, September 20, 2016 Des Plaines, IL Midwest Financial Reporting Symposium Focus on today s hottest issues with an all-star
More informationThe Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured?
The Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured? 2-3 April 2014 PROGRAMME Woodlands Park Hotel, Cobham, Surrey, UK CENTRE
More informationEUROPE March Brussels, Belgium CALL FOR ABSTRACTS. Join Us at the Crossroads of Healthcare. DIAglobal.org/Europe2020 #DIAEurope2020
EUROPE 2020 17-19 March Brussels, Belgium CALL FOR ABSTRACTS Join Us at the Crossroads of Healthcare I1 Steering Committee Francis Arickx INAMI, Belgium Matthieu Boudes EPF, Belgium Sini Eskola EFPIA,
More informationKEY HIGHLIGHTS WORKSHOP 2019
KEY HIGHLIGHTS aenvironmental Monitoring afacility Design apractical Case Studies avisual Inspection aclean Room Behaviours aprocess Simulations arecent 483s, warning Letters and EU Observations WORKSHOP
More informationInvitation ANNUAL ASSEMBLY 2018
Invitation ANNUAL ASSEMBLY 2018 Zurich, Monday, 9 July 2018, 17:00 Collective Redress: Magic Wand or Nightmare in Dispute Settlement? Keynote speaker: Prof. Christopher Hodges, Professor of Justice Systems,
More informationMAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals
MAH Responsibilities including the Management of CMOs QP Forum 2017 - Workshop Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals 25 th April 2017 Alexion Pharmaceuticals in Ireland A
More informationUS/GLOBAL BIOCIDES (ANTIMICROBIALS) REGULATION CONFERENCE
US/GLOBAL BIOCIDES (ANTIMICROBIALS) REGULATION CONFERENCE WASHINGTON DC A two-day Conference bringing together experts from the USA, Asia and Europe to discuss latest developments in the regulation of
More informationHealth Based Exposure Limits (HBEL) and Q&As
Health Based Exposure Limits (HBEL) and Q&As The EMA guideline (EMA/CHMP/ CVMP/ SWP/169430/2012) & EMA/CHMP/CVMP/SWP/463311/2016 Graeme McKilligan, UK, MHRA. Content Intent of HBEL Post Implementation
More informationFINANCIAL REPORTING: CURRENT ISSUES, FUTURE PERSPECTIVES
FINANCIAL REPORTING: CURRENT ISSUES, FUTURE PERSPECTIVES THE FINANCIAL REPORTING FACULTY S SECOND ANNUAL IFRS CONFERENCE 12 DECEMBER 2012, CHARTERED ACCOUNTANTS HALL, LONDON BUSINESS WITH CONFIDENCE icaew.com/frf
More informationThe Product Journey. An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation
The Product Journey An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation This one day conference will be held on 16th September The conference day will include speakers from
More information24-25 January 2013 PROGRAMME. Intercontinental Financial Street, Beijing, P.R. China
Regulatory Review How do agencies ensure the quality of the decision? The role of decision frameworks in the review of new medicines: What are the challenges and solutions that can facilitate agencies
More information2. Evidence themes and their importance along the development path
1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development
More informationUS/GLOBAL BIOCIDES (ANTIMICROBIALS) REGULATION CONFERENCE
US/GLOBAL BIOCIDES (ANTIMICROBIALS) REGULATION CONFERENCE WASHINGTON DC A two-day Conference bringing together experts from the USA, Asia and Europe to discuss latest developments in the regulation of
More informationSHTG primary submission process
Meeting date: 24 April 2014 Agenda item: 8 Paper number: SHTG 14-16 Title: Purpose: SHTG primary submission process FOR INFORMATION Background The purpose of this paper is to update SHTG members on developments
More informationRISK MANAGEMENT AND PHARMACOVIGILANCE SUMMIT SEPTEMBER 2017 I VIENNA
4TH ANNUAL RISK MANAGEMENT AND PHARMACOVIGILANCE SUMMIT 12-14 SEPTEMBER 2017 I VIENNA Pharmacovigilance Industry Market GROWTH, TRENDS AND ANALYSIS Safety Evaluation Regulatory Affairs Patient Support
More informationHong Kong Personal Data Protection Regulatory Framework From Compliance to Accountability
Legal Week s Corporate Counsel Forum 2016 Renaissance Harbour View Hotel 23 June 2016 Hong Kong Personal Data Protection Regulatory Framework From Compliance to Accountability Stephen Kai-yi Wong Privacy
More informationClinical Forum Attendee Sample Job Titles
Account Executive Account Manager Account Manager, New Sales Development - Europe Advisor, Global Medical Channels and ecapabilities Area Sales Director Assistant Director.Assistant Director Pharm. Tr.
More informationWhen digital meets postal - Evolution or revolution?
Brussels ERGP When digital meets postal - Evolution or revolution? ERGP stakeholder forum Brussels September 20th Thon Hotel Rue de la loi 75, 1040 Brussels What will be discussed Stakeholders from the
More information2016 PDA Data Integrity Workshop
The Parenteral Drug Association presents the... 2016 PDA Data Integrity Workshop April 19-20 I London, UK September 14-15 I Washington, DC November 8-9 I Berlin, Germany December 7-8 I San Diego, CA WORKSHOP
More information2015 Annual Conference
2015 Annual Conference British Compressed Gases Association Thursday 23 April 2015 Marriott Hotel & Country Club Worsley Park, Manchester, M28 2QT Programme: BCGA annual conference brings professionals
More informationIBC UK Conferences and Matrix Chambers bring you the second annual masterclass - Privacy. and the Media
Tuesday 13th June, 2006, Café Royal, London IBC UK Conferences and Matrix Chambers bring you the second annual masterclass - Privacy Places will be limited to ensure maximum discussion Discounts for team
More informationIMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters!
IMI Revolutionising Europe s Pharmaceutical Industry IMI Matters! Session in the Framework of the Event Joint Technology Initiatives Innovation in Action 4 6 October 2011 European Parliament Brussels Programme
More informationPergamon Corporation CONFRENCE
Pergamon Corporation CONFRENCE IP Stategy, Patent Portfolio Development and InnovationEarn CLE Dissecting the evolving spectrum of intellectual property rights, and licensing to foster innovation May 23-24,
More informationThe meeting was chaired by Mr. Sándor ERDŐ, representative of the Hungarian Presidency of the EU.
EUROPEAN UNION EUROPEAN RESEARCH AREA COMMITTEE High Level Group for Joint Programming Secretariat Brussels, 21 June 2011 ERAC-GPC 1302/11 NOTE Subject: Summary conclusions of the 15th meeting of the High
More informationConvergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA
EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,
More informationEDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS
EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE 1992-2012: 20 YEARS OF EXPERIENCE 22-23 March 2012 EDQM, Strasbourg, France ABSTRACTS PLENARY SESSION, 22 March 2012 ABSTRACT 1.3 The Evolution
More informationDate: Friday, March 24, 2017 Time: 8:30 AM 4:30 PM Location: Baruch College 55 Lexington Avenue, NYC
Date: Friday, March 24, 2017 Time: 8:30 AM 4:30 PM Location: Baruch College 55 Lexington Avenue, NYC Morning Workshop - 8:30 am - 11:30am (3 CPE) Presenter/Speaker David Kahan, Senior Manager, Ernst &
More informationMapping Your Success 2013 BSI Healthcare Road Show
Mapping Your Success 2013 BSI Healthcare Road Show Welcome & Outline Objectives for Today Please let me introduce myself.. Gary Slack Global Director BSI Medical Devices Based London 2 Changing Global
More informationMANAGEMENT ACCOUNTING CONFERENCE WHERE BUSINESS LEADERS ARE MADE MELBOURNE AUGUST 2017 RYDGES MELBOURNE
MANAGEMENT ACCOUNTING CONFERENCE WHERE BUSINESS LEADERS ARE MADE MELBOURNE 14 15 AUGUST 2017 RYDGES MELBOURNE BREXIT. TRUMP. UBER. AIRBNB. The decisions and advancements these disruptors and organisations
More informationPHARMA LAWCONVENTION
2-3 MARCH 2017 AUSTRIA TREND HOTEL SAVOYEN ****S VIENNA, AUSTRIA 6 th ANNUAL PHARMA LAWCONVENTION GOLD SPONSOR SILVER SPONSORS BRONZ SPONSOR OFFICIAL CARRIER IN PARTNERSHIP WITH ENDORSED BY Why should
More informationAnnual Meeting ISPE Japan Affiliate. Emerging Technology. - Age of Digital and Disruptive Innovation. Dates: 24th & 25th May, 2018
Annual Meeting 2018 ISPE Japan Affiliate Emerging Technology - Age of Digital and Disruptive Innovation Dates: 24th & 25th May, 2018 Place: Host: Tower Hall Funabori (Edogawa-ku, Tokyo) ISPE Japan Affiliate
More informationThe Challenge of the Non-Executive Director Aligning professional duties with stakeholder expectations
The Challenge of the Non-Executive Director Aligning professional duties with stakeholder expectations 16 November 2017 The Challenge of the Non-Executive Director Course outline This course will explore
More informationPDA 71 Years of Connecting People, Science and Regulation
PDA 71 Years of Connecting People, Science and Regulation 1 I m happy to be here. Bom Dia. Estou feliz por estar aqui. Richard M. Johnson PDA President & CEO since 2009 38 years experience in US and International
More informationMedical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade
Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association
More informationThe New Mexico Public Procurement Association 2009 Spring Conference & Vendor Fair March 11 th, 12 th, and 13 th, 2009 AGENDA
The New Mexico Public Procurement Association 2009 Spring Conference & Vendor Fair March 11 th, 12 th, and 13 th, 2009 AGENDA Wednesday, March 11, 2009 NOTE: WE ARE OFFERING TWO IN-STATE CERTIFICATION
More information52 nd AESGP Annual Meeting
52 nd AESGP Annual Meeting 31 May 2016-2 June 2016 Athens The future of self-care: Shaping the new environment Programme The future of self-care: Shaping the new environment Tuesday, 31 May to Thursday,
More informationDIGITALISING MANUFACTURING CONFERENCE 2017
DIGITALISING MANUFACTURING CONFERENCE 2017 Driving competitiveness and productivity of UK industry through digitalisation 30 & 31 October 2017 The Manufacturing Technology Centre Sponsored by: Conference
More informationPushing Boundaries, Changing Horizons
Pushing Boundaries, Changing Horizons The World Customs Organization and the Customs Administration of The Netherlands are pleased to announce the 5th WCO Technology & Innovation Forum, to be held in Rotterdam,
More informationConnecting the smart consumer
Connecting the smart consumer Advance programme 54 TH AESGP ANNUAL MEETING 5 7 June 2018, NH Grand Hotel Krasnapolsky Amsterdam, The Netherlands. BACKGROUND The AESGP Annual Meeting has for decades been
More informationOverview on Medicines Regulation: regulatory cooperation and harmonization in focus
Overview on Medicines Regulation: regulatory cooperation and harmonization in focus Dr Samvel Azatyan Manager, Medicines Regulatory Support Programme Quality Assurance and Safety: Medicines Essential Medicines
More informationSenior Management Quarterly Travel and Hospitality Expenses Q Ben Cowan-Dewar Chair, Board of Directors. Other Date(s) Purpose of Travel
Disclosure of Travel and Senior Management Quarterly Travel and Ben Cowan-Dewar Chair, Board of Directors of Travel 2018/2/28-2018/2/28 Board Meetings $866.71 $0.00 $0.00 $0.00 $0.00 $866.71 2018/03/06-2018/03/06
More information8 th Zurich Regional and Global Headquarters Conference
www.pwc.ch/hqzhconference 8 th Zurich Regional and Global Headquarters Conference Digital Economy, the evolving role of Swiss-based HQ s Wednesday, 31 October 2018 8.00 am to 2.00 pm Renaissance Tower
More informationENCePP Work Plan
EMA/231507/2012 ENCePP Secretariat European Network of Centres for Pharmacoepidemiology and Pharmacovigilance European Network of Centres for Pharmacoepidemiology and Pharmacovigilance Adopted by the ENCePP
More informationWorkshop Guide. Joint Regulators/Industry QbD Workshop January 2014 London, UK. europe.pda.org/ema2014
EMA together with other EU Health Agencies Joint Regulators/Industry QbD Workshop 28-29 January 2014 London, UK Workshop Guide europe.pda.org/ema2014 ORGANIZED BY PDA EUROPE Letter from the Chairs Dear
More informationInternal Governance within the Banking Industry: Issues and Developments MALTA April 2013
Seminar on Internal Governance within the Banking Industry: Issues and Developments MALTA 15-16 April 2013 Description The Seminar is primarily intended to provide participants with the opportunity to
More informationEU, USA and Japan (II) Reports from Regulators on Exchange Assignments
EU, USA and Japan (II) Reports from Regulators on Exchange Assignments Yoshikazu Hayashi MHLW/PMDA Liaison at EMA PMDA 24th Annual EuroMeeting 26-28 March 2012 Copenhagen, Denmark Disclaimer The views
More informationMARCH 21 24, 2018 COLORADO CONVENTION CENTER DENVER, CO
Guidelines for Commercially Supported Symposia (CME and NCE) HOPA 14TH ANNUAL CONFERENCE MARCH 21 24, 2018 COLORADO CONVENTION CENTER DENVER, CO Industry Partner, We invite you to participate in the Hematology/Oncology
More informationTGPL Compliance Forum Hosted by the Association of Latvian Commercial Banks Riga, Latvia June 14 th 15 th 2018
TGPL 2018 Compliance Forum Hosted by the Association of Latvian Commercial Banks June 14 th 15 th 2018 Thursday, June 14 th 08.00 Registration, Coffee & Networking 08.55 Welcome & Introduction Association
More information«INTERNAL AUDITORS AND AUDIT COMMITTEES» Key Elements for sound Corporate Governance
INVITATION L INSTITUT LUXEMBOURGEOIS DES ADMINISTRATEURS AND THE INSTITUTE OF INTERNAL AUDITORS LUXEMBOURG are pleased to invite you to the following conference: «INTERNAL AUDITORS AND AUDIT COMMITTEES»
More informationA Malaysian Technical Cooperation Programme (MTCP) ISLAMIC MARKETS PROGRAMME. Strengthening the Wellbeing of Societies
A Malaysian Technical Cooperation Programme (MTCP) 9 th ISLAMIC MARKETS PROGRAMME Strengthening the Wellbeing of Societies 11 14 August 2014 Securities Commission Malaysia, Kuala Lumpur 9th ISLAMIC MARKETS
More informationVALUE BASED HEALTHCARE. 20 th SEPTEMBER 2018 KINGDOM OF SAUDI ARABIA Venue : Riyadh Marriott Hotel, Riyadh, KSA
VALUE BASED HEALTHCARE 20 th SEPTEMBER 2018 KINGDOM OF SAUDI ARABIA Venue : Riyadh Marriott Hotel, Riyadh, KSA www.valuebasedhealth.org JOIN US FOR THE VALUE-BASED CARE SUMMIT, KSA TO HEAR FROM THE POLICY
More informationConnecting the smart consumer
Connecting the smart consumer Advance programme 54 TH AESGP ANNUAL MEETING 5 7 June 2018, NH Grand Hotel Krasnapolsky Amsterdam, The Netherlands. BACKGROUND The AESGP Annual Meeting has for decades been
More informationUKRI research and innovation infrastructure roadmap: frequently asked questions
UKRI research and innovation infrastructure roadmap: frequently asked questions Infrastructure is often interpreted as large scientific facilities; will this be the case with this roadmap? We are not limiting
More informationthe listed companies Title Agency Venue Date/Time Price: Members Price: Non- Members RM450 RM300 (Vouchers) 24 March 2010 / 9am to 5.
Title the role of PR in public listed companies Agency Asia Pacific Network of the Year, 2008 & 2004 :: MEDIA/PRWeek Best Use of Digital, 2009 & 2008 :: Malaysia PR Awards Gold Campaign of the Year, 2008
More informationEU s Innovative Medical Technology and EMA s Measures
EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency
More informationIntegrated Scientific Advice Workshop: ISPOR Glasgow
Integrated Scientific Advice Workshop: ISPOR Glasgow Early Integrated Scientific Advice in Product Development: Get Real and Adapt to Accelerate Patient Access ICONplc.com Overview At today s patient-centered
More information5 th Annual Pharma IPR Conference 2016
5 th Annual Pharma IPR Conference 2016 9 11 March 2016, Mumbai DAY 1 : 9 th March 2016 Country: US 09:40 American Invents Act Updates on Americas Invents Act and current scenario of US Patent laws Implications
More informationclarification to bring legal certainty to these issues have been voiced in various position papers and statements.
ESR Statement on the European Commission s proposal for a Regulation on the protection of individuals with regard to the processing of personal data on the free movement of such data (General Data Protection
More informationLife Sciences Regulatory
Life Sciences Regulatory Pharmaceuticals 2018 2 Life Sciences Regulatory Pharmaceuticals 2018 Top ranked in Chambers and Legal 500 for Life Sciences, pharmaceuticals and biotechnology. Allen & Overy LLP
More informationCOMMUNICATIONS POLICY
COMMUNICATIONS POLICY This policy was approved by the Board of Trustees on June 14, 2016 TABLE OF CONTENTS 1. INTRODUCTION 1 2. PURPOSE 1 3. APPLICATION 1 4. POLICY STATEMENT 1 5. ROLES AND RESPONSIBILITIES
More informationTuesday, 6 November 2018
Tuesday, 6 November 2018 08:00-09:00 Registration and Coffee 09:00-09:15 Opening Ceremony 09:15-09:30 Welcome Addresses 09:30-09:45 Awards Ceremony 09:45-10:45 Private Exhibition Tour 09:45-10:45 Keynote
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationPharmacovigilance System - EU
Pharmacovigilance System - EU Rechtsanwalt Prof. Burkhard Sträter Sträter Rechtsanwälte Kronprinzenstraße 20 Fon: +49 (0) 228-934 54-0 mail@straeterlawyers.de D-53173 Bonn Fax: +49 (0) 228-934 54-54 Pharmacovigilance
More informationNHS South Kent Coast. Clinical Commissioning Group. Complaints, Comments and Compliments Policy
NHS South Kent Coast Clinical Commissioning Group Complaints, Comments and Compliments Policy Version: Version 1.6 Ratified by: Date ratified: Name of originator/author: Name of responsible committee/individual:
More informationThe creation of the Emergency Preparedness and Response Expert Group (EPREG) which held its second meeting last month.
Remarks at SENIOR REGULATORS MEETING 19 September 2013 Good morning, Ladies and Gentlemen. I am pleased to welcome you to this meeting of Senior Regulators, which is an annual feature of the IAEA General
More informationTable Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...
Table Of Content... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D08 - HAI Europe Newsletter (EN)... 7 D01 - HAI Europe leaflet (EN)... 7 D02 - Briefing Papers and statements
More informationSUPPLY CHAIN TO VALUE CHAIN
21-22 MARCH 2018 THE OAKLEY COURT, WINDSOR, UK TOGETHER ADDING VALUE CO-ORGANISED BY GIRP AND HDA UK WINDSOR, UK CONFERENCE PROGRAMME CONFERENCE OBJECTIVES Present the latest state-of-the-art technologies
More informationICAS: Zimmer Biomet Hips Revision Course
ICAS: Zimmer Biomet Hips Revision Course Instructional Course with Anatomical Specimens Medical University Vienna Vienna, Austria 22-23 September 2015 Faculty: Prof. M. Pretterklieber - Host Dr. J. Retpen
More informationDeloitte Touche Tohmatsu LLC Annual seminar
With contributions from Annual seminar With contributions ti from the International ti Accounting Standards Committee Foundation Towards the Adoption of International Financial Reporting Standards in Japan
More informationAGENDA (draft) 5 th CRG BIO-BUSINESS SCHOOL
MODULE 1: Monday, September 17 AGENDA (draft) 5 th CRG BIO-BUSINESS SCHOOL Barcelona, 17-21 September 2018 Ramon y Cayal room (PRBB inner square) Researchers focus on their ongoing research and potential
More informationThe EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki
The EFPIA Perspective on the GDPR Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference 26-27.9.2017, Helsinki 1 Key Benefits of Health Data Improved decision-making Patient self-management CPD
More informationEeB-CA² Training: Innovation Management. Agenda. 15th June, 2016, Brussels, Belgium
EeB-CA² Training: Innovation Management Agenda 15th June, 2016, Brussels, Belgium Training Agenda Wednesday, 15 th June, 2016 9:00 Arrival, Registration 9:30 Presentation EeB-CA² project 9:45 Welcome,
More informationCONFERENCE AGENDA. Empowering Your Clinical Trial Operations Through Digital Innovation. 5 6 December 2018, Grand Copthorne Waterfront, Singapore
CONFERENCE AGENDA Empowering Your Clinical Trial Operations Through Digital Innovation 5 6 December 2018, Grand Copthorne Waterfront, Singapore Researched & Developed by CONFERENCE DAY ONE: WEDNESDAY,
More informationEVCA Institute. Finance and Administration Course November Brussels, Belgium. Private Equity Management Training
Private Equity Management Training Praise for Finance and Administration Course Most interesting topics in the PE environment are covered Finance and Administration Course 23-26 November 2010 - Brussels,
More informationParenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)
Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about
More informationAGM & Conference. 25 th January Marketing Pack
AGM & Conference 25 th January 2018 Marketing Pack Background Outstanding, Best conference I have been to for years, Fantastic well informed speakers just a few comments made by some of the near 100 attendees
More information